Testosterone Cypionate/Testosterone Enanthate Injection — Class II drug recall D-876-2013
Terminated recall by Pallimed Solutions, reported 2013-08-21, distributed nationwide. Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control
| Recall number | D-876-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pallimed Solutions, Woburn, MA, United States |
| Recall initiated | 2013-03-25 |
| Classified | 2013-08-09 |
| Reported by FDA | 2013-08-21 |
| Terminated | 2013-08-21 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
Product
Testosterone Cypionate/Testosterone Enanthate Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA
Reason for recall
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-876-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.